In an alternative line of investigation, when given enough time to develop in vivo (90–140 days post transplant), engraftment of pancreatic progenitor cells derived from human embryonic stem cells have been able to secrete insulin, and maintain normoglycaemia in a murine model of induced diabetes up until the grafts are removed [42]. Here, INS is linked to diabetes mellitus.